Computed tomography (CT) radiation dose can result in unnecessarily high exposures, placing patients at increased risk of cancer and other conditions. Inappropriate radiation doses have raised public concerns and attracted national media attention.


Hospitals, clinics and office-based physicians are increasingly turning to electronic medical records (EMRs) as they prepare for the impact of the Patient Protection and Affordable Health Care (PPAHC) act, says Albert Woodard, CEO of Atlanta-based Business Computer Applications, a company devoted to digitizing medical records.


The Society of Interventional Radiology (SIR), an international organization of doctors, scientists and allied health professionals dedicated to improving public health through minimally invasive, image-guided treatments, joined as a member of the "Rethink Varicose Veins" coalition, an alliance of organizations united to drive public awareness of the risks of varicose veins and chronic venous insufficiency.



St. Jude Medical Inc. announced enrollment of the first patient in the EnligHTN II trial. This post-market clinical study will further evaluate the safety and efficacy of the EnligHTN renal denervation system in patients with uncontrolled hypertension. 

 

St. Jude Medical Inc announced the first patient implant of its 25 mm Portico Transcatheter Aortic Heart Valve using the Transfemoral Delivery System in its ongoing European trial. The Portico valve system offers a minimally invasive treatment option for patients with severe aortic stenosis — a narrowing of the aortic valve that obstructs blood flow from the heart.

Nuclear Medicine Information Systems LLC (NMIS) and BioDose LLC have been renamed and rebranded as ec2 Software Solutions, company officials announced.

St. Jude Medical has issued a Class I recall for its Amplatzer TorqVue FX Delivery System used in transcatheter closure of atrial septal defects (ASDs). The company said in a small number of cases, the distal end of the core wire of the TorqVue FX system can fracture, which has the potential to cause serious adverse health consequences, including death.

Subscribe Now